Tat endolysosome escape and HAND
Tat 内溶酶体逃逸和 HAND
基本信息
- 批准号:10196977
- 负责人:
- 金额:$ 41.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAttenuatedBrainCalciumCell NucleusCellsChelating AgentsClinicalEndocytosisEndosomesEventFunctional disorderHIV-1HIV-associated neurocognitive disorderHigh PrevalenceImpaired cognitionIndividualInfectionIntegral Membrane ProteinLeadLearningLysosomesMeasuresMediatingMolecularNeuronal InjuryOutcomePathogenesisPathologyPlayPore ProteinsPrevalenceProcessProteolipidsProton PumpPublic HealthResearchRoleStructureSynapsesTestingTherapeutic InterventionTransactivationTransgenic MiceViralVirus ReplicationWorkantiretroviral therapybaseinnovationinsightneuroinflammationneuron lossneurotoxicitynovelnovel therapeutic interventionpreventpreventive interventionpromotersocialtherapeutically effectivevacuolar H+-ATPase
项目摘要
Project Abstract
Fundamental gaps exist in our understanding in Tat endolysosome escape and its role in the pathogenesis of
HIV-1 associated neurocognitive disorders (HAND). The objective here is to determine molecular mechanisms
by which Tat escapes endolysosomes, and the extent to which this escape contributes to neurotoxicity. We will
test our central hypothesis that Tat escapes endolysosomes through protein pores formed by the V0 sector of
v-ATPase, that this escape is facilitated by calcium released from endolysosome two-pore channels (TPCs),
and that such a calcium-dependent Tat endolysosome escape process, an upstream event of LTR
transactivation, precedes and contributes to Tat-induced neurotoxicity. Guided by our preliminary findings, this
novel hypothesis will be tested by pursuing three specific aims. (1) Determine the involvement of v-ATPase
and TPCs in Tat endolysosome escape. (2) Determine the involvement of v-ATPase and TPCs in Tat-induced
neurotoxicity. (3) Determine the involvement of v-ATPase and TPCs in Tat-induced learning and cognitive
impairment as well as HAND-like pathology in Tat transgenic mice. The proposed work is highly innovative
because it focuses on determining mechanisms by which Tat escapes endolysosomes via protein pores
formed by V0 sector of v-ATPase; a process that can be regulated by calcium released from endolysosomes.
Such a novel calcium-dependent Tat endolysosome escape process might be an early and upstream event of
Tat-induced neurotoxicity. Successful completion of the proposed studies will provide novel insights into HIV-1
infection and the pathogenesis of HAND and may yield new and effective therapeutic strategies against HAND.
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuesong Chen其他文献
Xuesong Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuesong Chen', 18)}}的其他基金
Intersection of HIV-1 Tat and SARS-CoV-2 S1 on neuroinflammation
HIV-1 Tat 和 SARS-CoV-2 S1 对神经炎症的交叉作用
- 批准号:
10755919 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
17α-estradiol and sex-differences in HAND with methamphetamine
17α-雌二醇和 HAND 与甲基苯丙胺的性别差异
- 批准号:
10759800 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
The role of novel endolysosome-dependent calcium regulatory mechanisms in HIV-1 T
新型内溶酶体依赖性钙调节机制在 HIV-1 T 中的作用
- 批准号:
8659832 - 财政年份:2014
- 资助金额:
$ 41.46万 - 项目类别:
Role of novel endolysosome-dependent calcium regulatory mechanisms in HAND
新型内溶酶体依赖性钙调节机制在 HAND 中的作用
- 批准号:
9176035 - 财政年份:2014
- 资助金额:
$ 41.46万 - 项目类别:
The role of novel endolysosome-dependent calcium regulatory mechanisms in HIV-1 T
新型内溶酶体依赖性钙调节机制在 HIV-1 T 中的作用
- 批准号:
9253443 - 财政年份:2014
- 资助金额:
$ 41.46万 - 项目类别:
Role of novel endolysosome-dependent calcium regulatory mechanisms in HAND
新型内溶酶体依赖性钙调节机制在 HAND 中的作用
- 批准号:
8986215 - 财政年份:2014
- 资助金额:
$ 41.46万 - 项目类别:
The role of novel endolysosome-dependent calcium regulatory mechanisms in HIV-1 T
新型内溶酶体依赖性钙调节机制在 HIV-1 T 中的作用
- 批准号:
8900341 - 财政年份:2014
- 资助金额:
$ 41.46万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 41.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 41.46万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 41.46万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 41.46万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 41.46万 - 项目类别:
Research Grant














{{item.name}}会员




